Caring Brands (CABR) Depreciation & Amortization (CF) (2024 - 2025)
Caring Brands (CABR) posted quarterly Depreciation & Amortization (CF) of $75000.0 for Q1 2025, down 50.0% quarter-over-quarter from $150000.0 in Q4 2024.
Caring Brands (CABR) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends
Caring Brands' Depreciation & Amortization (CF) history runs 2 years deep, the most recent figure standing at $75000.0 for Q1 2025.
- In Q1 2025, Depreciation & Amortization (CF) changed N/A year-over-year to $75000.0; the TTM figure through Mar 2026 stood at $75000.0 (changed N/A YoY), while the FY2025 annual figure was $300000.0, changed N/A from the prior year.
- Depreciation & Amortization (CF) for Q1 2025 stood at $75000.0, down from $150000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $150000.0 in Q4 2024, with the low at $75000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Caring Brands | 12.14 Mn | 10.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 75,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |